ReAlta is exploring the ability of RLS-0071 to treat acute lung injury and acute pulmonary exacerbations, such as Severe Asthma and Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD).
These small but well-defined patient populations do not benefit from existing therapies and have significant unmet need.
Normal lung histology 
Neutrophil infiltration and tissue damage 
Preserved lung histology after single dose of RLS-0071 
Acute lung injury (ALI) is the pulmonary manifestation of an acute systemic inflammatory process characterized clinically by pulmonary infiltrates, hypoxemia and edema.
Learn More
Hypoxic-ischemic encephalopathy (HIE) is a type of newborn brain damage caused by oxygen deprivation and limited blood flow.
Learn More
Platelet Refractoriness is common in cancer patients who receive frequent platelet transfusions and increases the risk of life-threatening hemorrhage.
Learn More
Autoimmune hemolytic anemia is a group of disorders characterized by a malfunction of the immune system that produces autoantibodies, which attack red blood cells as if they were substances foreign to the body.
Learn More